Relief Therapeutics Holding SA logo

Relief Therapeutics Holding SA

0001854078

MindMaze Therapeutics is a leader in developing innovative neurotherapeutic combinations, encompassing behavior, software, devices, and data. They offer a treatment ecosystem that redefines the future of brain repair and neurological recovery. Their platform integrates various therapies to improve patient outcomes.

85
Altamente Confiable
Puntuación de Confianza

Registro Oficial

Número de IVA
000000000
Dirección
AVENUE DE SECHERON 15, CH-1202 GENEVA, V8 NA
Códigos de Industria
Pharmaceutical Preparations, 2834

Análisis de Calidad IA

Industria
Biotechnology
SSL/HTTPS
Seguro
Correo profesional
Correo de contacto
01info@mindmaze.com

Desglose de Puntuación de Confianza

Registro Verificado35/35
Puntuación de Calidad50/60
Sentimiento de Noticias0/5

Enlaces Rápidos

Destacados del sitio web

Última actualización: 1/2/2026

🌟 Empresas similares de confianza

vTv Therapeutics Inc.

vTv Therapeutics Inc. logo
89/100 · Altamente Confiable

vTv Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of diabetes patients. They focus on developing oral, small molecule drug candidates. Their lead candidate is cadisegliatin, a potential adjunctive therapy to insulin for type 1 diabetes. They are also exploring indications for type 2 diabetes and other chronic conditions.

3980 PREMIER DR, Estados Unidos
Ver perfil

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. logo
86/100 · Altamente Confiable

Bolt Biotherapeutics is a clinical-stage biotech company working to harness the power of the immune system to improve lives and eradicate cancer. The company is developing novel immunotherapies using foreign patterns to trigger the innate immune system, which teaches the immune system to recognize and kill cancer. Bolt was founded in 2015.

900 CHESAPEAKE DRIVE, Estados Unidos
Ver perfil

IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC. logo
86/100 · Altamente Confiable

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. They are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors.

825 INDUSTRIAL ROAD, Estados Unidos
Ver perfil